| 661 Neoantigen-specific CD4+ T cells in human melanoma have diverse differentiation states and correlate with CD8+ T cell, macrophage, and B cell function N Singhi, C Shasha, S Lee, J Szeto, A Moshiri, T Kim, J Thompson, ... Journal for ImmunoTherapy of Cancer 9 (Suppl 2), A689-A689, 2021 | 1 | 2021 |
| 694 IMMUNE PROFILING IDENTIFIES IMMUNOSUPPRESSIVE CELLS IN PANCREATIC NEUROENDOCRINE TUMORS (PNETS) K Rico, JL Mudd, RC Fields, VG Pillarisetty Gastroenterology 166 (5), S-161-S-162, 2024 | | 2024 |
| A Contemporary Large Single Institution Evaluation of Retroperi-toneal Sarcoma Treatment: Have We Managed to ove Past the Scalpel Yet? P Bremjit, RL Jones, DR Byrd, G Kane, X Chai, E Rodler, E Loggers, ... ANNALS OF SURGICAL ONCOLOGY 20, S122-S122, 2013 | | 2013 |
| A contemporary large single-institution evaluation of resected retroperitoneal sarcoma PJ Bremjit, RL Jones, X Chai, G Kane, ET Rodler, ET Loggers, SM Pollack, ... Annals of surgical oncology 21, 2150-2158, 2014 | 82 | 2014 |
| A novel rat model for the study of postoperative pancreatic fistula AF Utria, KP Labadie, A Abbasi, X Gui, VG Pillarisetty, JO Park, JG Sham Laboratory Animals 56 (6), 519-527, 2022 | | 2022 |
| A phase II study of perioperative therapy for patients with resectable and borderline-resectable pancreatic adenocarcinoma. AL Coveler, VG Pillarisetty, G Gyurkey, WJ Koh, M Upton, C Cuevas, ... Journal of Clinical Oncology 32 (15_suppl), 4120-4120, 2014 | 3 | 2014 |
| A phase II trial of lanreotide for the prevention of postoperative pancreatic fistula VG Pillarisetty, A Abbasi, JO Park, JG Sham HPB 24 (11), 2029-2034, 2022 | 5 | 2022 |
| A phase II trial of pembrolizumab and vorinostat in recurrent metastatic head and neck squamous cell carcinomas and salivary gland cancer CP Rodriguez, Q Wu, J Voutsinas, JR Fromm, X Jiang, VG Pillarisetty, ... Clinical Cancer Research 26 (4), 837-845, 2020 | 146 | 2020 |
| Abstract P037: Interleukin-10 is a dominant and reversible mechanism of immune evasion in human colorectal cancer liver metastasis TS Kim, K Sullivan, X Jiang, C Hsu, K Labadie, K Kohli, H Kenerson, ... Cancer Immunology Research 10 (1_Supplement), P037-P037, 2022 | | 2022 |
| Adenovirus infection enhances dendritic cell immunostimulatory properties and induces natural killer and T-cell-mediated tumor protection G Miller, S Lahrs, VG Pillarisetty, AB Shah, RP DeMatteo Cancer research 62 (18), 5260-5266, 2002 | 137 | 2002 |
| Analysis of differentiation changes and outcomes at time of first recurrence of retroperitoneal liposarcoma by transatlantic australasian retroperitoneal sarcoma working group … C Nessim, CP Raut, D Callegaro, F Barretta, R Miceli, M Fairweather, ... Annals of surgical oncology 28 (12), 7854-7863, 2021 | 14 | 2021 |
| Are enhanced recovery protocols after pancreatoduodenectomy still efficient when applied in elderly patients? A systematic review and individual patient data meta‐analysis C Kuemmerli, G Balzano, SA Bouwense, M Braga, M Coolsen, SK Daniel, ... Journal of Hepato‐Biliary‐Pancreatic Sciences 31 (5), 308-317, 2024 | 1 | 2024 |
| ASO Visual Abstract: An Analysis of Differentiation Changes and Outcomes at the First Recurrence of Retroperitoneal Liposarcoma by the Transatlantic Australasian … C Nessim, CP Raut, D Callegaro, F Barretta, R Miceli, M Fairweather, ... Annals of surgical oncology 28, 490-491, 2021 | | 2021 |
| Biliary obstruction selectively expands and activates liver myeloid dendritic cells JI Bleier, SC Katz, UI Chaudhry, VG Pillarisetty, TP Kingham, AB Shah, ... The Journal of Immunology 176 (12), 7189-7195, 2006 | 43 | 2006 |
| Biopolymers codelivering engineered T cells and STING agonists can eliminate heterogeneous tumors TT Smith, HF Moffett, SB Stephan, CF Opel, AG Dumigan, X Jiang, ... The Journal of clinical investigation 127 (6), 2176-2191, 2017 | 299 | 2017 |
| Blockade of interleukin 10 potentiates antitumour immune function in human colorectal cancer liver metastases KM Sullivan, X Jiang, P Guha, C Lausted, JA Carter, C Hsu, KP Labadie, ... Gut 72 (2), 325-337, 2023 | 64 | 2023 |
| CD11c identifies a subset of murine liver natural killer cells that responds to adenoviral hepatitis BM Burt, G Plitas, JA Stableford, HM Nguyen, ZM Bamboat, VG Pillarisetty, ... Journal of Leucocyte Biology 84 (4), 1039-1046, 2008 | 46 | 2008 |
| Challenges in assessing solid tumor responses to immunotherapy LF Chai, E Prince, VG Pillarisetty, SC Katz Cancer gene therapy 27 (7), 528-538, 2020 | 47 | 2020 |
| Choledochal cysts: a clinicopathologic study of 36 cases with emphasis on the morphologic and the immunohistochemical features of premalignant and malignant alterations N Katabi, VG Pillarisetty, R DeMatteo, DS Klimstra Human Pathology 45 (10), 2107-2114, 2014 | 56 | 2014 |
| Combination CXCR4 and PD-1 blockade increases T cell infiltration and effector function in fibrolamellar carcinoma (FLC) LK Dickerson, R van den Bijgaart, X Jiang, SK Daniel, JA Carter, A Farghli, ... Cancer Research 84 (6_Supplement), 2710-2710, 2024 | | 2024 |
